Herbalife (NYSE:HLF) PT Lowered to $9.50 at DA Davidson

Herbalife (NYSE:HLF) had its target price lowered by DA Davidson from $11.00 to $9.50 in a report published on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other equities analysts have also recently commented on the company. Mizuho decreased their target price on Herbalife from $12.00 to $10.00 and set a neutral rating on the stock in a report on Thursday, March 21st. Bank of America decreased their target price on Herbalife from $10.00 to $8.00 and set an underperform rating on the stock in a report on Thursday, March 21st. Finally, StockNews.com raised Herbalife from a hold rating to a buy rating in a report on Friday, February 16th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $10.50.

Herbalife Price Performance

NYSE HLF opened at $9.48 on Monday. The business’s fifty day moving average price is $10.12 and its 200-day moving average price is $12.56. The stock has a market capitalization of $945.51 million, a price-to-earnings ratio of 6.67 and a beta of 1.21. Herbalife has a 1-year low of $6.68 and a 1-year high of $19.48.

Herbalife (NYSE:HLF) last released its quarterly earnings results on Wednesday, February 14th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.10). The firm had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.19 billion. Herbalife had a net margin of 2.81% and a negative return on equity of 19.56%. Herbalife’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.53 earnings per share. Equities research analysts anticipate that Herbalife will post 1.8 EPS for the current year.

Insiders Place Their Bets

In other Herbalife news, EVP Henry C. Wang purchased 2,778 shares of the business’s stock in a transaction on Tuesday, March 26th. The stock was acquired at an average price of $9.30 per share, for a total transaction of $25,835.40. Following the purchase, the executive vice president now owns 176,194 shares of the company’s stock, valued at approximately $1,638,604.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Henry C. Wang acquired 2,778 shares of the business’s stock in a transaction dated Tuesday, March 26th. The stock was purchased at an average price of $9.30 per share, for a total transaction of $25,835.40. Following the completion of the transaction, the executive vice president now directly owns 176,194 shares in the company, valued at approximately $1,638,604.20. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, Director Juan Miguel Mendoza acquired 16,079 shares of the business’s stock in a transaction dated Tuesday, March 26th. The shares were purchased at an average price of $9.40 per share, with a total value of $151,142.60. Following the transaction, the director now owns 54,622 shares of the company’s stock, valued at $513,446.80. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 85,757 shares of company stock worth $723,278. Corporate insiders own 0.94% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD grew its position in Herbalife by 1.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 67,737 shares of the company’s stock worth $1,348,000 after acquiring an additional 705 shares in the last quarter. Ameritas Investment Partners Inc. grew its position in Herbalife by 9.9% in the second quarter. Ameritas Investment Partners Inc. now owns 8,166 shares of the company’s stock worth $108,000 after acquiring an additional 736 shares in the last quarter. Envestnet Asset Management Inc. grew its position in Herbalife by 6.5% in the first quarter. Envestnet Asset Management Inc. now owns 12,308 shares of the company’s stock worth $374,000 after acquiring an additional 747 shares in the last quarter. Exchange Traded Concepts LLC grew its position in Herbalife by 3.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 26,496 shares of the company’s stock worth $404,000 after acquiring an additional 929 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its position in Herbalife by 150.0% in the first quarter. Nomura Asset Management Co. Ltd. now owns 1,900 shares of the company’s stock worth $31,000 after acquiring an additional 1,140 shares in the last quarter.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.